Daiichi Sankyo to pay $39M to settle DOJ claims it paid kickbacks to docs

Japanese drugmaker Daiichi Sankyo will pay $39 million to state and federal health programs, and a whistleblower, to settle claims it paid doctors kickbacks to prescribe some of its drugs, Reuters reports. The settlement, the Justice Department said, stemmed from a whistleblower lawsuit filed by former Daiichi sales representative Kathy Fragoules. She will get $6.1 million of the settlement. The drugmaker was accused of enticing doctors with speaking fees and lavish dinners, sometimes to speak only to their own staffs, the government contended. Story

Suggested Articles

Alexion Pharmaceuticals names its first chief diversity officer as the rare disease specialist looks to cultivate diversity and inclusion.

BMS executives pointed to upcoming Opdivo data releases, as well as strong demand for other drugs in the portfolio, as reasons for optimism.

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back.